Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity ...
BioPharma Dive1h
Lilly CEO wields manufacturing plans to push pharma-friendly policies
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...
Eli Lilly aims to invest in ‘big problems hiding in plain sight' using obesity windfall
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
AFP on MSN3h
Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories
US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...
Eli Lilly Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since October 2023 — Data Talk
Eli Lilly Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since October 2023 — Data Talk Eli Lilly and Company (LLY) is currently at $915.07, up $13.27 or 1.47% --Would be ...
Committee Stocks on the Move: Lowe's, TJX Companies, Eli Lilly and the XLV
The Investment Committee discuss some of their stocks that are moving today. Trump says Zelenskyy to visit U.S. to sign ...
Eli Lilly launches additional Zepbound doses
Eli Lilly (LLY) announced the launch of 7.5 mg and 10 mg Zepbound single-dose vials, available for $499 with the new Zepbound Self Pay Journey ...